| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701301 | European Journal of Surgical Oncology (EJSO) | 2017 | 9 Pages |
Abstract
After CCRS plus HIPEC, serosal recurrences were more common than their distant counterparts. Distant relapses' emergence has raised the question of their optimal treatments. Very long-term survival can be obtained after further treatment of recurrent PMP for patients with limited disease and good general status.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J.-B. Delhorme, C. Honoré, L. Benhaim, F. Dumont, P. Dartigues, C. Dromain, M. Ducreux, D. Elias, D. Goéré,